Elanix Biotechnologies competitorsClear all

Elanix Biotechnologies's top competitors include E-Qure, InspireMD, Soligenix and Procyon.
Elanix Biotechnologies
Elanix Biotechnologies
Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications.
E-Qure
E-Qure
E-QURE developed a non-invasive, electrical stimulation (ES), medical device that cures Hard-to-Heal wounds and Ulcers.
InspireMD
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Soligenix
Soligenix
Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
Procyon
Procyon
Procyon Corporation develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States.
Founding Date
Founding Date
2012
Founding Date
2014
Founding Date
2005
Founding Date
1987
Founding Date
1987
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Frankfurt am Main, DE HQ
Epalinges, CH
Nyon, CH
Locations
New York, US HQ
Locations
Tel Aviv-Yafo, IL HQ
Winsen (Luhe), DE
Locations
Princeton, US HQ
Locations
Clearwater, US HQ
Employees
Employees
1122% increase
Employees
1
Employees
4319% increase
Employees
1422% decrease
Employees
176% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.6 m
Valuation ($)
13.1 m
Valuation ($)
72.2 m
Valuation ($)
2 m
Twitter followers
Twitter followers
33
Twitter followers
351
Twitter followers
951
Twitter followers
623
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15
Average likes per tweet (last 30 days)
3.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
290800
Alexa Website Rank
408258
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
1.3
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
€328.1k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$3.7m (FY, 2019)
Revenue (est.)
$4.6m (FY, 2019)
Revenue (est.)
$4.3m (FY, 2020)
Cost of goods
Cost of goods
€157.6k (FY, 2017)
Cost of goods
N/A
Cost of goods
$3m (FY, 2019)
Cost of goods
$3.6m (FY, 2019)
Cost of goods
$1.1m (FY, 2020)
Gross profit
Gross profit
€170.5k (FY, 2017)
Gross profit
N/A
Gross profit
$756k (FY, 2019)
Gross profit
$1.1m (FY, 2019)
Gross profit
$3.2m (FY, 2020)
Net income
Net income
€3.8m (FY, 2017)
Net income
($436.8k) (FY, 2019)
Net income
($10m) (FY, 2019)
Net income
($9.4m) (FY, 2019)
Net income
$111.7k (FY, 2020)
For sources of this data, please see the company profile

View company profiles

E-Qure
HQ
New York, US
Employees
1

E-QURE developed a non-invasive, electrical stimulation (ES), medical device that cures Hard-to-Heal wounds and Ulcers.

View company
InspireMD
HQ
Tel Aviv-Yafo, IL
Employees
43↑ 19% increase

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

View company
Soligenix
HQ
Princeton, US
Employees
14↓ 22% decrease

Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.

View company
Procyon
HQ
Clearwater, US
Employees
17↑ 6% increase

Procyon Corporation develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States.

View company